Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 - 2025

  • ID: 4582064
  • Report
  • 258 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Ardagh Group S.A.
  • Beatson Clark
  • Bormioli Pharma S.r.l
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • MORE
The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025, registering a CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in developed as well as developing economies is projected to drive the demand for pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical industry and is traditionally used for parenteral drug packaging. Extensive R&D is being conducted by product manufacturers in order to minimize negative aspects of glass, such as high susceptibility to breaking and delamination, as well as to improve the quality & efficacy of the product.

The pharmerging market is anticipated to witness phenomenal growth owing to favorable government policies and increased healthcare awareness. Governments of developing nations are expanding their public or private healthcare coverage and simultaneously making efforts to minimize out-of-pocket medical expenses for the consumers. Increasing government efforts to reduce healthcare cost and promotion of low-cost generic drugs are estimated to fuel the utilization of glass packaging over the coming years.

Emergence of novel drugs such as cancer drugs and bio-therapeutics is likely to help the market gain traction over the coming years. In an effort to safeguard patient health, guidelines for packaging of biological drugs have been made highly stringent, which necessitates constant development in the field of pharmaceutical packaging. Aforementioned factors promote manufacturers to adopt advanced techniques, thereby driving the market.

In primary pharmaceutical packaging, glass has an advantage over plastic as plastic production requires raw materials such as polyethylene, polypropylene, and polystyrene, which are largely dependent on fluctuating petroleum industry. Manufacturers use soda lime, quartz, and other additives for manufacturing glass. These raw materials are easily available in the market by numerous suppliers. Recent developments in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017. This technology has the ability to minimize particle loads and meet strict requirements for therapeutic protein products for better deliver of drug.

Further Key Findings from the Report Suggest:
  • The vials segment is projected to ascend at a CAGR of 6.9% in terms of revenue over the forecast period
  • The bottles segment dominated the global pharmaceutical glass packaging market in 2016 in terms of revenue and is anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high penetration of plastics in the manufacturing of bottles
  • The generic drug segment accounted for 69.8% of the market in 2016 due to rapidly increasing manufacturing volumes of generic drugs in emerging economies
  • Europe is expected to witness considerable growth during the forecast period owing to constant development in the medical field aimed at improving health and quality of life
  • Some of the key companies present in the market are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT AG; Sisecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato Group; and Owens-Illinois, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ardagh Group S.A.
  • Beatson Clark
  • Bormioli Pharma S.r.l
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • MORE
Chapter 1 Methodology And Scope
1.1 Research methodology
1.2 Research scope & assumptions
1.3 List of data sources

Chapter 2 Executive Summary
2.1 Market snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Penetration & growth prospect mapping
3.2 Pharmaceutical glass packaging - Value chain analysis
3.3 Raw material trend
3.3.1 Type I - Borosilicate glass (e.g. Pyrex, Borosil)
3.3.2 Boric oxide
3.3.3 Type II Treated soda-lime glass
3.3.4 Type III Regular soda-lime glass
3.4 Regulatory framework
3.4.1 International Organization for Standardization
3.4.2 Occupational Health and Safety Management Certification
3.4.3 US Food and Drug Administration
3.5 Market dynamics
3.5.1 Market driver analysis
3.5.1.1 Growth of pharmaceutical industry in emerging economies
3.5.1.2 Commodity value of glass increased with recyclability:
3.5.2 Market restraint analysis
3.5.2.1 Increased relevance of alternate sources
3.5.2.2 Challenges associated with glass surface
3.6 Pharmaceutical glass packaging market - PESTEL analysis
3.7 Pharmaceutical glass packaging market - Porter’s analysis

Chapter 4 Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
4.1 Pharmaceutical glass packaging market: Product movement analysis
4.2 Vials
4.2.1 Pharmaceutical glass vials market estimates & forecasts, 2014 - 2025 (USD Million)
4.2.2 Pharmaceutical glass vials packaging market estimates & forecasts, by product, 2014 - 2025 (USD Million)
4.3 Bottles
4.3.1 Pharmaceutical glass bottle market estimates & forecasts, 2014 - 2025 (USD Million)
4.3.2 Pharmaceutical glass bottle market estimates & forecasts, by product, 2014 - 2025 (USD Million)
4.4 Cartridges & Syringes
4.4.1 Pharmaceutical glass cartridges & syringes market estimates & forecasts, 2014 - 2025 (USD Million)
4.5 Ampoules
4.5.1 Pharmaceutical glass ampoules market estimates & forecasts, 2014 - 2025 (USD Million)

Chapter 5 Pharmaceutical Glass Packaging Market: Drug Type Estimates & Trend Analysis
5.1 Pharmaceutical glass packaging market: Drug type movement analysis
5.1.1 Generic drugs
5.1.1.1 Pharmaceutical glass packaging market estimates & forecasts in generic drugs, 2014 - 2025 (USD Million)
5.1.2 Branded drugs
5.1.2.1 Pharmaceutical glass packaging market estimates & forecasts in branded drugs, 2014 - 2025 (USD Million)
5.1.3 Biologic drugs
5.1.3.1 Pharmaceutical glass packaging market demand in biologic drugs, 2014 - 2025 (USD Million)

Chapter 6 Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2016 & 2025
6.2 North America Movement Analysis & Market Share, 2016 & 2025
6.2.1 North America market estimates and forecast, by product (USD Million)
6.2.2 North America market estimates and forecast, by drug type (USD Million)
6.2.3 U.S. pharmaceutical glass packaging market share, 2016 & 2025
6.2.3.1 U.S. market estimates and forecast, by product (USD Million)
6.2.3.2 U.S. market estimates and forecast, by drug type (USD Million)
6.3 Europe Movement Analysis & Market Share, 2016 & 2025
6.3.1 Europe market estimates and forecast, by product (USD Million)
6.3.2 Europe market estimates and forecast, by drug type (USD Million)
6.3.3 Germany pharmaceutical glass packaging market share, 2016 & 2025
6.3.3.1 Germany market estimates and forecast, by product (USD Million)
6.3.3.2 Germany market estimates and forecast, by drug type (USD Million)
6.3.4 U.K. pharmaceutical glass packaging market share, 2016 & 2025
6.3.4.1 U.K. market estimates and forecast, by product (USD Million)
6.3.4.2 U.K. market estimates and forecast, by drug type (USD Million)
6.3.5 France pharmaceutical glass packaging market share, 2016 & 2025
6.3.5.1 France market estimates and forecast, by product (USD Million)
6.3.5.2 France market estimates and forecast, by drug type (USD Million)
6.3.6 Spain pharmaceutical glass packaging market share, 2016 & 2025
6.3.6.1 Spain market estimates and forecast, by product (USD Million)
6.3.6.2 Spain market estimates and forecast, by drug type (USD Million)
6.3.7 Italy pharmaceutical glass packaging market share, 2016 & 2025
6.3.7.1 Italy market estimates and forecast, by product (USD Million)
6.3.7.2 Italy market estimates and forecast, by drug type (USD Million)
6.4 Asia Pacific Movement Analysis & Market Share, 2016 & 2025
6.4.1 Asia Pacific market estimates and forecast, by product (USD Million)
6.4.2 Asia Pacific market estimates and forecast, by drug type (USD Million)
6.4.3 China pharmaceutical glass packaging market share, 2016 & 2025
6.4.3.1 China market estimates and forecast, by product (USD Million)
6.4.3.2 China market estimates and forecast, by drug type (USD Million)
6.4.4 Japan pharmaceutical glass packaging market share, 2016 & 2025
6.4.4.1 Japan market estimates and forecast, by product (USD Million)
6.4.4.2 Japan market estimates and forecast, by drug type (USD Million)
6.4.5 India pharmaceutical glass packaging market share, 2016 & 2025
6.4.5.1 India market estimates and forecast, by product (USD Million)
6.4.5.2 India market estimates and forecast, by drug type (USD Million)
6.4.6 South Korea pharmaceutical glass packaging market share, 2016 & 2025
6.4.6.1 South Korea market estimates and forecast, by product (USD Million)
6.4.6.2 South Korea market estimates and forecast, by drug type (USD Million)
6.5 CSA Movement Analysis & Market Share, 2016 & 2025
6.5.1 CSA market estimates and forecast, by product (USD Million)
6.5.2 CSA market estimates and forecast, by drug type (USD Million)
6.5.3 Brazil pharmaceutical glass packaging market share, 2016 & 2025
6.5.3.1 Brazil market estimates and forecast, by product (USD Million)
6.5.3.2 Brazil market estimates and forecast, by drug type (USD Million)
6.6 MEA Movement Analysis & Market Share, 2016 & 2025
6.6.1 MEA market estimates and forecast, by product (USD Million)
6.6.2 MEA market estimates and forecast, by drug type (USD Million)

Chapter 7 Competitive Landscape
7.1 Competitive environment
7.2 Price Trend Analysis
7.3 Vendor landscape
7.4 Strategy framework
7.5 Company Market Positioning
7.6 List Of Key Pharma Companies, By Country
7.6.1 U.S.
7.6.1.1 Johnson & Johnson Services, Inc.
7.6.1.1.1 Company overview
7.6.1.1.2 Regional Sales
7.6.1.1.3 Drug Portfolio
7.6.1.2 Pfizer Inc.
7.6.1.2.1 Company overview
7.6.1.2.2 Regional Sales
7.6.1.2.3 Drug Portfolio
7.6.1.3 Abbott
7.6.1.3.1 Company overview
7.6.1.3.2 Regional Sales
7.6.1.3.3 Drug Portfolio
7.6.1.4 Bristol-Myers Squibb Company
7.6.1.4.1 Company overview
7.6.1.4.2 Regional Sales
7.6.1.4.3 Drug Portfolio
7.6.1.5 Amgen Inc.
7.6.1.5.1 Company overview
7.6.1.5.2 Regional Sales
7.6.1.5.3 Drug Portfolio
7.6.1.6 Biogen
7.6.1.6.1 Company overview
7.6.1.6.2 Regional Sales
7.6.1.6.3 Drug Portfolio
7.6.1.7 Celgene Corporation
7.6.1.7.1 Company overview
7.6.1.7.2 Regional Sales
7.6.1.7.3 Drug Portfolio
7.6.1.8 Merck & Co., Inc.
7.6.1.8.1 Company overview
7.6.1.8.2 Regional Sales
7.6.1.8.3 Drug Portfolio
7.6.1.9 Eli Lilly and Company
7.6.1.9.1 Company overview
7.6.1.9.2 Regional Sales
7.6.1.9.3 Drug Portfolio
7.6.1.10 Gilead Sciences, Inc.
7.6.1.10.1 Company overview
7.6.1.10.2 Regional Sales
7.6.1.10.3 Drug Portfolio
7.6.2 Germany
7.6.2.1 Bayer AG
7.6.2.1.1 Company overview
7.6.2.1.2 Regional Sales
7.6.2.1.3 Drug Portfolio
7.6.2.2 PHOENIX Pharma SE
7.6.2.2.1 Company overview
7.6.2.2.2 Regional Sales
7.6.2.3 LEO Pharma A/S
7.6.2.3.1 Company overview
7.6.2.3.2 Regional Sales
7.6.2.3.3 Drug Portfolio
7.6.2.4 Boehringer Ingelheim International GmbH.
7.6.2.4.1 Company overview
7.6.2.4.2 Regional Sales
7.6.2.4.3 Drug Portfolio
7.6.2.5 B. Braun Melsungen AG
7.6.2.5.1 Company overview
7.6.2.5.2 Regional Sales
7.6.2.5.3 Drug Portfolio
7.6.2.6 Grünenthal Group
7.6.2.6.1 Company overview
7.6.2.6.2 Regional Sales
7.6.2.6.3 Drug Portfolio
7.6.2.7 AbbVie Inc.
7.6.2.7.1 Company overview
7.6.2.7.2 Regional Sales
7.6.2.7.3 Drug Portfolio
7.6.2.8 Baxter
7.6.2.8.1 Company overview
7.6.2.8.2 Regional Sales
7.6.2.8.3 Drug Portfolio
7.6.2.9 H. Lundbeck A/S
7.6.2.9.1 Company overview
7.6.2.9.2 Drug Portfolio
7.6.2.10 Medigene Ag
7.6.2.10.1 Company overview
7.6.2.10.2 Regional Sales
7.6.2.10.3 Drug Portfolio
7.6.3 France
7.6.3.1 Servier Laboratories
7.6.3.1.1 Company overview
7.6.3.1.2 Drug Portfolio
7.6.3.2 Sanofi S.A.
7.6.3.2.1 Company overview
7.6.3.2.2 Regional Sales
7.6.3.2.3 Drug Portfolio
7.6.3.3 Allergan plc
7.6.3.3.1 Company overview
7.6.3.3.2 Drug Portfolio
7.6.3.4 Novo Nordisk A/S
7.6.3.4.1 Company overview
7.6.3.4.2 Regional Sales
7.6.3.4.3 Drug Portfolio
7.6.3.5 Mylan N.V
7.6.3.5.1 Company overview
7.6.3.5.2 Regional Sales
7.6.3.5.3 Drug Portfolio
7.6.3.6 BioMarin Pharmaceutical Inc.
7.6.3.6.1 Company overview
7.6.3.6.2 Regional Sales
7.6.3.6.3 Drug Portfolio
7.6.3.7 ALK-Abelló A/S
7.6.3.7.1 Company overview
7.6.3.7.2 Regional Sales
7.6.3.7.3 Drug Portfolio
7.6.3.8 Bristol Laboratories Ltd
7.6.3.8.1 Company overview
7.6.3.8.2 Drug Portfolio
7.6.3.9 Regeneron Pharmaceuticals, Inc.
7.6.3.9.1 Company overview
7.6.3.9.2 Regional Sales
7.6.3.9.3 Drug Portfolio
7.6.3.10 Sinclair Pharma plc
7.6.3.10.1 Company overview
7.6.3.10.2 Regional Sales
7.6.3.10.3 Drug Portfolio
7.6.4 U.K.
7.6.4.1 GlaxoSmithKline plc.
7.6.4.1.1 Company overview
7.6.4.1.2 Regional Sales
7.6.4.1.3 Drug Portfolio
7.6.4.2 AstraZeneca
7.6.4.2.1 Company overview
7.6.4.2.2 Regional Sales
7.6.4.2.3 Drug Portfolio
7.6.4.3 Reckitt Benckiser Group plc.
7.6.4.3.1 Company overview
7.6.4.3.2 Regional Sales
7.6.4.3.3 Drug Portfolio
7.6.4.4 Novartis AG
7.6.4.4.1 Company overview
7.6.4.4.2 Regional Sales
7.6.4.4.3 Drug Portfolio
7.6.4.5 F. Hoffmann-La Roche Ltd
7.6.4.5.1 Company overview
7.6.4.5.2 Drug Portfolio
7.6.4.6 Norgine BV
7.6.4.6.1 Company overview
7.6.4.6.2 Regional Sales
7.6.4.6.3 Drug Portfolio
7.6.4.7 Vifor Pharma Group
7.6.4.7.1 Company overview
7.6.4.7.2 Regional Sales
7.6.4.7.3 Drug Portfolio
7.6.4.8 Concordia International Corp.
7.6.4.8.1 Company overview
7.6.4.8.2 Regional Sales
7.6.4.8.3 Drug Portfolio
7.6.4.9 Shire Pharmaceuticals Group
7.6.4.9.1 Company overview
7.6.4.9.2 Regional Sales
7.6.4.9.3 Drug Portfolio
7.6.4.10 Vectura Group plc
7.6.4.10.1 Company overview
7.6.4.10.2 Regional Sales
7.6.4.10.3 Drug Portfolio
7.6.5 India
7.6.5.1 Sun Pharmaceutical Industries Ltd
7.6.5.1.1 Company overview
7.6.5.1.2 Regional Sales
7.6.5.1.3 Drug Portfolio
7.6.5.2 Lupin Limited
7.6.5.2.1 Company overview
7.6.5.2.2 Regional Sales
7.6.5.2.3 Drug Portfolio
7.6.5.3 Dr. Reddy’s Laboratories Ltd
7.6.5.3.1 Company overview
7.6.5.3.2 Regional Sales
7.6.5.3.3 Drug Portfolio
7.6.5.4 Cipla Inc.
7.6.5.4.1 Company overview
7.6.5.4.2 Regional Sales
7.6.5.4.3 Drug Portfolio
7.6.5.5 Aurobindo Pharma Limited
7.6.5.5.1 Company overview
7.6.5.5.2 Regional Sales
7.6.5.5.3 Drug Portfolio
7.6.5.6 Zydus Cadila
7.6.5.6.1 Company overview
7.6.5.6.2 Regional Sales
7.6.5.6.3 Drug Portfolio
7.6.5.7 Glenmark Pharmaceuticals Ltd.
7.6.5.7.1 Company overview
7.6.5.7.2 Regional Sales
7.6.5.7.3 Drug Portfolio
7.6.5.8 Torrent Pharmaceuticals Ltd
7.6.5.8.1 Company overview
7.6.5.8.2 Regional Sales
7.6.5.8.3 Drug Portfolio
7.6.5.9 Piramal Enterprises Ltd
7.6.5.9.1 Company overview
7.6.5.9.2 Drug Portfolio
7.6.5.10 Novozymes
7.6.5.10.1 Company overview
7.6.5.10.2 Regional Sales
7.6.6 Spain
7.6.6.1 ESTEVE PHARMA
7.6.6.1.1 Company overview
7.6.6.1.2 Drug Portfolio
7.6.6.2 Curaxys
7.6.6.2.1 Company overview
7.6.6.2.2 Drug Portfolio
7.6.6.3 GRIFOLS INTERNATIONAL, S.A.
7.6.6.3.1 Company overview
7.6.6.3.2 Regional Sales
7.6.6.3.3 Drug Portfolio
7.6.6.4 PharmaMar
7.6.6.4.1 Company overview
7.6.6.4.2 Drug Portfolio
7.6.6.5 SOM Innovation Biotech, S.L.
7.6.6.5.1 Company overview
7.6.6.5.2 Drug Portfolio
7.6.6.6 Ferrer Internacional, S.A.
7.6.6.6.1 Company overview
7.6.6.6.2 Drug Portfolio
7.6.6.7 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
7.6.6.7.1 Company overview
7.6.6.7.2 Regional Sales
7.6.6.7.3 Drug Portfolio
7.6.6.8 A. Menarini Industrie Farmaceutiche Riunite Srl
7.6.6.8.1 Company overview
7.6.6.8.2 Drug Portfolio
7.6.6.9 ADIENNE
7.6.6.9.1 Company overview
7.6.6.9.2 Drug Portfolio
7.6.7 China
7.6.7.1 Shanghai Pharmaceuticals Holding Co., Ltd
7.6.7.1.1 Company overview
7.6.7.1.2 Regional Sales
7.6.7.1.3 Drug Portfolio
7.6.7.2 Weigao group
7.6.7.2.1 Company overview
7.6.7.2.2 Regional Sales
7.6.7.3 CSPC Pharmaceutical Group Limited
7.6.7.3.1 Company overview
7.6.7.3.2 Regional Sales
7.6.7.3.3 Drug Portfolio
7.6.7.4 Furen Pharmaceutical Group Co., Ltd.
7.6.7.4.1 Company overview
7.6.7.4.2 Drug Portfolio
7.6.7.5 China Resources Pharmaceutical Group Limited
7.6.7.5.1 Company overview
7.6.7.5.2 Drug Portfolio
7.6.7.6 Sino Biopharmaceutical Limited
7.6.7.6.1 Company overview
7.6.7.6.2 Drug Portfolio
7.6.7.7 Humanwell Healthcare (Group) Co., Ltd
7.6.7.7.1 Company overview
7.6.7.7.2 Drug Portfolio
7.6.7.8 Sihuan Pharmaceutical Holdings Group Ltd.
7.6.7.8.1 Company overview
7.6.7.8.2 Drug Portfolio
7.6.8 Japan
7.6.8.1 Takeda Pharmaceutical Company Limited
7.6.8.1.1 Company overview
7.6.8.1.2 Regional Sales
7.6.8.1.3 Drug Portfolio
7.6.8.2 Daiichi Sankyo Company, Limited
7.6.8.2.1 Company overview
7.6.8.2.2 Regional Sales
7.6.8.2.3 Drug Portfolio
7.6.8.3 Astellas Pharma Inc.
7.6.8.3.1 Company overview
7.6.8.3.2 Regional Sales
7.6.8.3.3 Drug Portfolio
7.6.8.4 Eisai Co., Ltd.
7.6.8.4.1 Company overview
7.6.8.4.2 Regional Sales
7.6.8.4.3 Drug Portfolio
7.6.8.5 Mitsubishi Tanabe Pharma Corporation
7.6.8.5.1 Company overview
7.6.8.5.2 Drug Portfolio
7.6.8.6 Kyowa Hakko Kirin Co., Ltd
7.6.8.6.1 Company overview
7.6.8.6.2 Regional Sales
7.6.8.6.3 Drug Portfolio
7.6.8.7 Nippon Shinyaku Co Ltd
7.6.8.7.1 Company overview
7.6.8.7.2 Drug Portfolio
7.6.8.8 OtsU.K.a Holdings Co Ltd
7.6.8.8.1 Company overview
7.6.8.8.3 Drug Portfolio
7.6.8.9 Shionogi & Co., Ltd.
7.6.8.9.1 Company overview
7.6.8.9.2 Regional Sales
7.6.8.9.3 Drug Portfolio
7.6.8.10 Dainippon Sumitomo Pharma Co., Ltd.
7.6.8.10.1 Company overview
7.6.8.10.2 Regional Sales
7.6.8.10.3 Drug Portfolio
7.6.9 South Korea
7.6.9.1 YUHAN
7.6.9.1.1 Company overview
7.6.9.1.2 Drug Portfolio
7.6.9.2 Aju Pharm Co. Ltd
7.6.9.2.1 Company overview
7.6.9.2.2 Drug Portfolio
7.6.9.3 Republic of Korea Arlico Pharm. Co., Ltd.
7.6.9.3.1 Company overview
7.6.9.3.2 Drug Portfolio
7.6.9.4 Binex Co., Ltd.
7.6.9.4.1 Company overview
7.6.9.4.2 Drug Portfolio
7.6.9.5 Boryung Pharmaceutical Co., Ltd.
7.6.9.5.1 Company overview
7.6.9.5.2 Drug Portfolio
7.6.9.6 CHO-A PHARM.CO., LTD
7.6.9.6.1 Company overview
7.6.9.6.2 Drug Portfolio
7.6.9.7 CHONG KUN DANG PHARMACEUTICAL CORP
7.6.9.7.1 Company overview
7.6.9.7.2 Drug Portfolio
7.6.9.8 CJ HealthCare Corp.
7.6.9.8.1 Company overview
7.6.9.8.2 Drug Portfolio
7.6.9.9 Hanmi Pharm.Co., Ltd.
7.6.9.9.1 Company overview
7.6.9.9.2 Drug Portfolio
7.6.9.10 Celltrion
7.6.9.10.1 Company overview
7.6.9.10.2 Drug Portfolio
7.6.10 Brazil
7.6.10.1 Aché Laboratórios Farmacêuticos S.A
7.6.10.1.1 Company overview
7.6.10.1.2 Drug Portfolio
7.6.10.2 Hypermarcas
7.6.10.2.1 Company overview
7.6.10.2.2 Drug Portfolio
7.6.10.3 Eurofarma Laboratórios S.A.
7.6.10.3.1 Company overview
7.6.10.3.2 Regional Sales
7.6.10.4 Libbs Farmaceutica Ltd.
7.6.10.4.1 Company overview
7.6.10.4.2 Drug Portfolio
7.6.10.5 União Química
7.6.10.5.1 Company overview
7.6.10.5.2 Drug Portfolio
7.6.10.6 Blanver Farmacêutica
7.6.10.6.1 Company overview
7.6.10.6.2 Drug Portfolio
7.6.10.7 CHIESI Farmaceutici S.p.A.
7.6.10.7.1 Company overview
7.6.10.7.2 Regional Sales
7.6.10.7.3 Drug Portfolio
7.6.10.8 Huvepharma
7.6.10.8.1 Company overview
7.6.10.8.2 Drug Portfolio

Chapter 8 Company Profiles
8.1 Corning Incorporated
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Nipro Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 SGD S.A.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Stölzle-Oberglas GmbH
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.5 West Pharmaceutical Services, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.6 Schott AG
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Gerresheimer AG
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Bormioli Pharma S.r.l
8.8.1 Company overview
8.8.2 Product benchmarking
8.8.3 Strategic Initiatives
8.9 Shandong Medicinal Glass Co., Ltd.
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.10 Beatson Clark
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 Ardagh Group S.A.
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.12 Arab Pharmaceutical Glass Co.
8.12.1 Company overview
8.12.2 Product benchmarking
8.13 Piramal Enterprises Ltd.
8.13.1 Company overview
8.13.2 Financial performance
8.13.3 Product benchmarking
8.14 Sisecam Group
8.14.1 Company overview
8.14.2 Financial performance
8.14.3 Product benchmarking
8.14.4 Strategic initiatives

List of Tables
Table 1 Pharmaceutical glass vials market estimates & forecasts, 2014 - 2025 (USD Million)
Table 2 Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
Table 3 Pharmaceutical glass bottle market estimates & forecasts, 2014 - 2025 (USD Million)
Table 4 Pharmaceutical glass bottle market value, by product, 2014 - 2025 (USD Million)
Table 5 Pharmaceutical glass cartridges & syringes market estimates & forecasts, 2014 - 2025 (USD Million)
Table 6 Pharmaceutical glass ampoules market estimates & forecasts, 2014 - 2025 (USD Million)
Table 7 Pharmaceutical glass packaging market estimates & forecasts in generic drugs, 2014 - 2025 (USD Million)
Table 8 Pharmaceutical glass packaging market estimates & forecasts in branded drugs, 2014 - 2025 (USD Million)
Table 9 Global pharmaceutical glass packaging market estimates & forecasts in biologic drugs, 2014 - 2025 (USD Million)
Table 10 North America pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
Table 11 North America pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
Table 12 North America pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
Table 13 North America pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
Table 14 U.S. pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
Table 15 U.S. Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TAB
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Corning Incorporated
  • Nipro Corporation
  • SGD S.A.
  • Stölzle-Oberglas GmbH
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Bormioli Pharma S.r.l
  • Shandong Medicinal Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A.
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Sisecam Group
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll